Found: 31
Select item for more details and to access through your institution.
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.75427
- By:
- Publication type:
- Article
Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protection.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.75427
- By:
- Publication type:
- Article
Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 7, p. 1, doi. 10.1371/journal.ppat.1006489
- By:
- Publication type:
- Article
Long-lasting severe immune dysfunction in Ebola virus disease survivors.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17489-7
- By:
- Publication type:
- Article
Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)-Specific T Cell Responses in Primary HIV Infection.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 5, p. 748
- By:
- Publication type:
- Article
Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.
- Published in:
- BMC Immunology, 2016, v. 17, p. 1, doi. 10.1186/s12865-016-0182-8
- By:
- Publication type:
- Article
Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 11, p. 1, doi. 10.1371/journal.ppat.1005995
- By:
- Publication type:
- Article
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.
- Published in:
- PLoS Neglected Tropical Diseases, 2024, v. 18, n. 4, p. 1, doi. 10.1371/journal.pntd.0011500
- By:
- Publication type:
- Article
HIV 'Elite Controllers' Are Characterized by a High Frequency of Memory CD8+CD73+ T Cells Involved in the Antigen-Specific CD8+ T-cell Response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
HIV “Elite Controllers” Are Characterized by a High Frequency of Memory CD8+CD73+ T Cells Involved in the Antigen-Specific CD8+ T-cell Response.
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. 9, p. 1321, doi. 10.1093/infdis/jit643
- By:
- Publication type:
- Article
Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 3, p. 1, doi. 10.1371/journal.ppat.1004752
- By:
- Publication type:
- Article
Quantifying and Predicting the Effect of Exogenous Interleukin-7 on CD4<sup>+</sup>T Cells in HIV-1 Infection.
- Published in:
- PLoS Computational Biology, 2014, v. 10, n. 5, p. 1, doi. 10.1371/journal.pcbi.1003630
- By:
- Publication type:
- Article
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 9, p. 2802, doi. 10.1002/eji.201344433
- By:
- Publication type:
- Article
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060884
- By:
- Publication type:
- Article
Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1949, doi. 10.1093/cid/ciad037
- By:
- Publication type:
- Article
Durable natural killer cell responses after heterologous two-dose Ebola vaccination.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00280-0
- By:
- Publication type:
- Article
HIV VIRION PROFILING SUGGEST THAT CXCR3+CD4 T CELLS ARE THE MAIN HIV-PRODUCING CELLS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 167
- By:
- Publication type:
- Article
CD40.HIVRI.Env VACCINE INDUCES STRONG AND DURABLE IMMUNE RESPONSES: ANRS VRI06 TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 129
- By:
- Publication type:
- Article
Targeting human langerin promotes HIV-1 specific humoral immune responses.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 7, p. 1, doi. 10.1371/journal.ppat.1009749
- By:
- Publication type:
- Article
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51453-z
- By:
- Publication type:
- Article
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0207794
- By:
- Publication type:
- Article
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
- Published in:
- Journal of Clinical Immunology, 2020, v. 40, n. 8, p. 1082, doi. 10.1007/s10875-020-00839-x
- By:
- Publication type:
- Article
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00874
- By:
- Publication type:
- Article
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153484
- By:
- Publication type:
- Article
Déficit des réponses lymphocytaires T CD8 spécifiques du VIH: Les lymphocytes T régulateurs sont-ils les coupables?
- Published in:
- Médecine Sciences, 2017, v. 33, n. 8/9, p. 723, doi. 10.1051/medsci/20173308012
- By:
- Publication type:
- Article
Inter-individual variability in Ca[sup 2+] signalling in platelets from healthy volunteers: effects of aspirin and relationship with expression of endomembrane Ca[sup 2+]-ATPases.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 3, p. 850, doi. 10.1046/j.1365-2141.1998.00844.x
- By:
- Publication type:
- Article
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 6, p. 1, doi. 10.1371/journal.ppat.1008522
- By:
- Publication type:
- Article
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 9, p. 1, doi. 10.1371/journal.ppat.1008011
- By:
- Publication type:
- Article